CASE REPORT
Unusual cause of skin nodules in a child – case report
 
More details
Hide details
1
Department of Paediatric Bone Marrow Transplantation, Oncology, and Haematology, Wroclaw Medical University, Wroclaw, Poland
 
2
Department of General and Interventional Radiology and Neuroradiology, Wroclaw Medical University, Wroclaw, Poland
 
3
Department of Pathomorphology, Wroclaw Medical University, Wroclaw, Poland
 
 
Submission date: 2019-07-15
 
 
Final revision date: 2019-08-12
 
 
Acceptance date: 2019-08-23
 
 
Publication date: 2019-09-19
 
 
Pediatr Pol 2019;94(4):271-275
 
KEYWORDS
TOPICS
ABSTRACT
We report a four-year-old boy with a skin lesion that was misdiagnosed as an abscess and unsuccessfully treated with systemic antibiotics and drainage. Due to its progression, the child underwent a biopsy, which revealed myeloid sarcoma. The histopathological verification at the referral centre changed the diagnosis to an anaplastic large-cell lymphoma (ALCL) with internal organ involvement. This subtype of paediatric lymphoma usually manifests as a systemic disease, and isolated skin infiltration is rare. The patient was treated according to the ALCL-99 protocol and achieved remission. Five months later a systemic lymph-node relapse was diagnosed. Salvage chemotherapy was administered and allogeneic stem cell transplantation was performed, which resulted in sustained remission. Skin infiltrates are commonly seen in children, and routine diagnostics is usually sufficient for a proper medical care. The diagnostic difficulties in the reported patient emphasise the need for observation and invasive diagnostics in non-responding cases.
REFERENCES (21)
1.
Fogelson S, Dohil M. Papular and Nodular Skin Lesions in Children. Semin Plast Surg 2006; 20: 180-191.
 
2.
Hoeger PH. Differential Diagnosis of Skin Nodules and Cysts. In: Harper’s Textbook of Pediatric Dermatology (3rd ed.), Irvine AD, Hoeger PH, Yan AC (eds.). Wiley-Blackwell, Oxford, UK 2011: 92.1-92.9.
 
3.
Hamm H, Höger PH. Skin Tumors in Childhood. Dtsch Arztebl Int 2011; 108: 347.
 
4.
Yang W, Zuo Y, Yang Y, et al. Pediatric anaplastic large cell lymphoma misdiagnosed as multiple organ abscesses: a case report and literature review. Int J Clin Exp Med 2015; 8: 19509-19516.
 
5.
Stevens DL, Bisno AL, Chambers HF, et al. Executive Summary: Practice Guidelines for the Diagnosis and Management of Skin and Soft Tissue Infections: 2014 Update by the Infectious Diseases Society of America. Clin Infect Dis 2014; 59: 147-159.
 
6.
Stein H, Mason DY, Gerdes J, et al. The expression of the Hodgkin’s disease associated antigen Ki-1 in reactive and neoplastic lymphoid tissue: evidence that Reed-Sternberg cells and histiocytic malignancies are derived from activated lymphoid cells. Blood 1985; 66: 848-858.
 
7.
Swerdlow SH, Campo E, Pileri SA, et al. The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood 2016; 127: 2375-2390.
 
8.
Turner SD, Lamant L, Kenner L, et al. Anaplastic large cell lymphoma in paediatric and young adult patients. Br J Haematol 2016; 173: 560-572.
 
9.
Montes-Mojarro I, Steinhilber J, Bonzheim I, et al. The Pathological Spectrum of Systemic Anaplastic Large Cell Lymphoma (ALCL). Cancers (Basel) 2018; 10: 107.
 
10.
Hsu FY, Johnston PB, Burke KA, Zhao Y. The Expression of CD30 in Anaplastic Large Cell Lymphoma Is Regulated by Nucleophosmin-Anaplastic Lymphoma Kinase-Mediated JunB Level in a Cell Type-Specific Manner. Cancer Res 2006; 66: 9002-9008.
 
11.
Wan W, Albom MS, Lu L, et al. Anaplastic lymphoma kinase activity is essential for the proliferation and survival of anaplastic large-cell lymphoma cells. Blood 2006; 107: 1617-1623.
 
12.
Stein H, Foss HD, Dürkop H, et al. CD30(+) anaplastic large cell lymphoma: a review of its histopathologic, genetic, and clinical features. Blood 2000; 96: 3681-3695.
 
13.
Li Y-P, Busch RK, Valdez BC, et al. C23 Interacts with B23, A Putative Nucleolar-Localization-Signal-Binding Protein. Eur J Biochem 1996; 237: 153-158.
 
14.
Larose H, Burke GAA, Lowe EJ, et al. From bench to bedside: the past, present and future of therapy for systemic paediatric ALCL, ALK +. Br J Haematol 2019; 185: 1043-1054.
 
15.
Diamantidis MD, Myrou AD. Perils and Pitfalls Regarding Differential Diagnosis and Treatment of Primary Cutaneous Anaplastic Large-Cell Lymphoma. Sci World J 2011; 11: 1048-1055.
 
16.
Kumar S, Pittaluga S, Raffeld M, et al. Primary Cutaneous CD30-Positive Anaplastic Large Cell Lymphoma in Childhood: Report of 4 Cases and Review of the Literature. Pediatr Dev Pathol 2005; 8: 52-60.
 
17.
Van Wering ER, Koningen J, Laene-Bruyn E, et al. ALCL 99. International protocol for the treatment of childhood anaplastic large cell lymphoma https://www.skion.nl/workspace... (accessed 7 July 2019).
 
18.
Mori T, Takimoto T, Katano N, et al. Recurrent childhood anaplastic large cell lymphoma: a retrospective analysis of registered cases in Japan. Br J Haematol 2006; 132: 594-597.
 
19.
Brugières L, Quartier P, Le Deley MC, et al. Relapses of childhood anaplastic large-cell lymphoma: treatment results in a series of 41 children – a report from the French Society of Pediatric Oncology. Ann Oncol Off J Eur Soc Med Oncol 2000; 11: 53-58.
 
20.
ALCL-Relapse. Treatment protocol for relapsed anaplastic large cell lymphoma of childhood and adolescence. Amended Version II March 2012 https://ptohd.pl/download/alcl...# (accessed 7 July 2019).
 
21.
Prokoph N, Larose H, Lim M, et al. Treatment Options for Paediatric Anaplastic Large Cell Lymphoma (ALCL): Current Standard and beyond. Cancers (Basel) 2018; 10: 99.
 
Journals System - logo
Scroll to top